| Group IT (n = 9) | Group SA (n = 6) |
---|---|---|
Age, median (range) | 66 (57–75) | 77 (63–90) |
Gender | Male | Male |
Histological cell type | Â | Â |
Squamous cell carcinoma | 6 | 1 |
Adenocarcinoma | 3 | 4 |
Large cell carcinoma | 0 | 1 |
Clinical stage | Â | Â |
1 | 0 | 4 |
2 | 0 | 2 |
3 | 9 | 0 |
T1aN2 | 1 | Â |
T2bN2 | 3 | Â |
T3N1 | 3 | Â |
T3N2 | 2 | Â |
Pathological stage* | Â | Â |
0 | 4 | 0 |
1 | 2 | 4 |
2 | 0 | 2 |
3 | 3 | 0 |
T1aN2 | 1 | Â |
T1bN2 | 1 | Â |
T3N1 | 1 | Â |
Pathological effect | Â | Â |
Complete response | 4 | - |
Major response | 4 | - |
Minor response | 1 | - |
Operative procedure | Â | Â |
Lobectomy** | 6 | 6 |
Pneumonectomy | 3 | 0 |